![](/img/cover-not-exists.png)
Cost-Utility Analysis of Melphalan plus Prednisone With or Without Interferon-α2b in Newly Diagnosed Multiple Myeloma
Dr Erik Nord,Finn Wisøff,Martin Hjorth,Jan WestinVolume:
12
Language:
english
Journal:
PharmacoEconomics
DOI:
10.2165/00019053-199712010-00009
Date:
July, 1997
File:
PDF, 2.35 MB
english, 1997